 Connection
Mark Connelly to Neoplastic Cells, Circulating
This is a "connection" page, showing publications Mark Connelly has written about Neoplastic Cells, Circulating.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.538 |
|
|
|
-
Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani A, Langer C, Albelda S. Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. Lung Cancer. 2017 10; 112:118-125.
Score: 0.157
-
Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ. Development of a Novel c-MET-Based CTC Detection Platform. Mol Cancer Res. 2016 06; 14(6):539-47.
Score: 0.142
-
Schwed Lustgarten DE, Thompson J, Yu G, Vachani A, Vaidya B, Rao C, Connelly M, Udine M, Tan KS, Heitjan DF, Albelda S. Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Ann Am Thorac Soc. 2013 Dec; 10(6):582-9.
Score: 0.121
-
Bitting RL, Boominathan R, Rao C, Kemeny G, Foulk B, Garcia-Blanco MA, Connelly M, Armstrong AJ. Development of a method to isolate circulating tumor cells using mesenchymal-based capture. Methods. 2013 Dec 01; 64(2):129-36.
Score: 0.118
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|